IRLAB to Present Clinical and Preclinical Data at The AD/PD(TM) 2026 - 20th International Conference on Alzheimer's & Parkinson's Diseases
GOTHENBURG, SE / ACCESS Newswire / March 17, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company
Norfolk Daily News
via Norfolk Daily News
Updated 1d ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Phishers Abuse LiveChat Support Tools to Steal Sensitive Data in New SaaS-Based Attack Tactic
Next
Analyzing MacroGenics (NASDAQ:MGNX) & ImmuCell (NASDAQ:ICCC)
Related Articles
HealthAMOREM seeks volunteers with certified therapy dogs in Caldwell, Burke counties
News Herald-13h ago-1 sources
HealthPeople in polyamorous relationships fight 'shame,' demand legal protections
Los Angeles Times-13h ago-1 sources
HealthRespect the voters on Medicaid expansion
Idaho Mountain Express Newspaper-13h ago-1 sources